Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.
Read more on NPR
May 29, 2019 at 12:56AM
Health Care
NPR News: Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Related Posts:
NPR News: More Than 10,000 People Have Now Died From COVID-19 In The U.S.- NPR News: Irish Leader Returns To Medicine To Help Battle COVID-19 Pandemic
- NPR News: Surgical Mask Manufacturer In Texas Is Inundated With Requests
- NPR News: Surgical Mask Manufacturer In Texas Is Inundated With Requests
- NPR News: Irish Leader Returns To Medicine To Help Battle COVID-19 Pandemic
0 nhận xét:
Đăng nhận xét